Crossover RCT in 32 patients with nonobstructive hypertrophic cardiomyopathy: bisoprolol lowered peak VO2 vs placebo (-2.5 mL/kg/min) and vs verapamil (-1.8); verapamil did not change it vs placebo. Bisoprolol also worsened KCCQ score and raised NT-proBNP.
RCTn = 32 patients
Bjerregaard et al. Beta-Blocker (Bisoprolol) vs Calcium-Channel Blocker (Verapamil) in Nonobstructive Hypertrophic Cardiomyopathy: A Randomized Triple-Crossover Physiologic Trial